| AUC | Area under the curve |
| AML | Acute myeloid leukemia |
| CAPP-Seq | Cancer Personalized Profiling by Deep Sequencing |
| CCGA | Circulating Cell-free Genome Atlas |
| CfDNA | Cell-free DNA |
| CHIP | Clonal hematopoiesis of indeterminate potential |
| CtDNA | Circulating tumor DNA |
| CT | Computed tomography |
| CTCs | Circulating tumor cells |
| DC | Dendritic cell |
| DEASH | Differential enrichment of allele-specific hybrids |
| E6/E7 | HPV oncogenes E6 and E7 |
| EMT | Epithelial–mesenchymal transition |
| EpCAM | Epithelial cell adhesion molecule |
| EVs | Extracellular vesicles |
| HNSCC | Head and neck squamous cell carcinoma |
| HPV | Human papillomavirus |
| HPV16 | Human papillomavirus type 16 |
| HR | Hazard ratio |
| LA-HNSCC | Locally advanced head and neck squamous cell carcinoma |
| MRD | Minimal residual disease |
| miRNA/miR | MicroRNA |
| MRI | Magnetic resonance imaging |
| NaME-PrO | Nuclease-assisted minor-allele enrichment with probe overlap |
| NGS | Next-generation sequencing |
| OSCC | Oral squamous cell carcinoma |
| PET | Positron emission tomography |
| PBMC | Peripheral blood mononuclear cell |
| VAF | Variant allele fraction |